DISCOVERY THERAPEUTICS INC has a total of 33 patent applications. Its first patent ever was published in 1985. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are NEUROCHEM INT LTD, KANDULA MAHESH and YAUPON THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | Canada | 6 | |
#4 | Australia | 5 | |
#5 | EPO (European Patent Office) | 4 | |
#6 | Ireland | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Sugars | |
#5 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Mcafee Donald A | 9 |
#2 | Peck James V | 8 |
#3 | Minaskanian Gevork | 8 |
#4 | Martin Pauline L | 6 |
#5 | Olsson Ray A | 6 |
#6 | Uwaydah Ibrahim M | 5 |
#7 | Cusack Noel J | 5 |
#8 | Wysocki Ronald J | 5 |
#9 | Thompson Robert D | 4 |
#10 | Moses L Meredith | 4 |
Publication | Filing date | Title |
---|---|---|
WO0137845A1 | Treatment of heart rhythm disturbances with n6-substituted-5'-(n-substituted) carboxamidoadenosines | |
CA2295195A1 | Compositions and methods for preventing restenosis following revascularization procedures | |
CA2198701A1 | Substituted 9-alkyladenines | |
WO9525514A1 | Compounds useful as anxiolytic, sedative, and hypnotic agents | |
US5565566A | N6 -substituted 9-methyladenines: a new class of adenosine receptor antagonists | |
US5670501A | N-substituted 9-alkyladenines | |
US5477857A | Diagnostic uses of hydrazinoadenosines | |
USRE36494E | 2-aralkoxy and 2-alkoxy adenosine derivatives as coronary vasodilators and antihypertensive agents | |
CA1340361C | N6-substituted 9-methyladenines: a new class of adenosine receptor antagonists |